MI-463
MI-463 is a potent inhibitor of Menin-MLL interaction (IC₅₀ = 15.3 nM). Pharmacologic inhibition of the menin-mLL interaction substantially delays progression of mLL leukemia in murine models through on-target activity without causing toxicity. MI-463 induces strong inhibition of tumor growth with once daily intraperitoneal administration.
Product Specifications
Shipping Conditions
Gel Pack
Storage Conditions
-20ºC
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
040226-AP 200 µL
PNPLA6, CT (PNPLA6, NTE, Neuropathy target esterase, Patatin-like phospholipase domain-containing protein 6) (AP) discontinued
Sign In for Pricing
View Details 
N8574-10-APC 200 µL
NYREN18, NT (NEDD8 Ultimate Buster-1, NUB1, Negative Regulator Of Ubiquitin-like Proteins 1, Renal Carcinoma Antigen NY-REN-18, NUB1) (APC) discontinued
Sign In for Pricing
View Details MBS6234053-01 0.1 mL
NAV2 (Neuron Navigator 2, Helicase APC Down-regulated 1, Pore Membrane and/or Filament-interacting-like Protein 2, Retinoic Acid Inducible in Neuroblastoma 1, Steerin-2, Unc-53 Homolog 2, unc53H2, HELAD1, KIAA1419, POMFIL2, RAINB1, STEERIN2, FLJ10633, FLJ
Sign In for Pricing
View Details MBS6234053-02 5x 0.1 mL
NAV2 (Neuron Navigator 2, Helicase APC Down-regulated 1, Pore Membrane and/or Filament-interacting-like Protein 2, Retinoic Acid Inducible in Neuroblastoma 1, Steerin-2, Unc-53 Homolog 2, unc53H2, HELAD1, KIAA1419, POMFIL2, RAINB1, STEERIN2, FLJ10633, FLJ
Sign In for Pricing
View Details